Abstract
Introduction: Epithelial ovarian cancer (EOC) is a disease with a poor survival rate mostly due to its discovery in late stages. Currently, beside clinical and imaging evaluation, measurement of the serum concentrations of CA125 and HE4 are the most widely used blood biomarkers for epithelial ovarian cancer, yet they lack sufficient specificity and sensitivity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Obstetrics & Gynecology and Reproductive Biology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
